Skip to main content

adenoviral psa vaccine etbx-071

Generic: Adenoviral PSA Vaccine ETBX-071

adenoviral psa vaccine etbx-071: 2 clinical trials tracked.

adenoviral psa vaccine etbx-071 evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about adenoviral psa vaccine etbx-071, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence0 indications · 1 study sponsors

Related indications

No linked indication is available.

Clinical Trial Registry Records (2)

Open-Label, Phase 2 Clinical Trial of Pre-Surgery and Post-Surgery Immunotherapy With N-803, ETBX-071, and M-CENK in Combination With Surgery for Participants With High-Risk Prostate Cancer Pre-Prostatectomy.

NCT06765902Registry updated 2026-05-05·Phase 2·IBRX
Withdrawn

Primary endpoint: Event-free survival (EFS)

Interventionalopen0 targetStarted 2025-12Completion 2031-06ImmunityBio, Inc.

Open-Label, Phase 2 Clinical Trial of Pre-Radiation and Post-Radiation Immunotherapy With N-803, ETBX-071, and M-CENK in Combination With Radiation for Participants With High-Risk Prostate Cancer

NCT06765954Registry updated 2026-05-05·Phase 2·IBRX
Withdrawn

Primary endpoint: Complete Pathologic Response (CPR) after pre-radiation immunotherapy.

Interventionalopen0 targetStarted 2025-12Completion 2031-06ImmunityBio, Inc.